These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 4053037

  • 21. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P.
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [Abstract] [Full Text] [Related]

  • 22. Effect of pH of the T4 polynucleotide kinase reaction on the 32P-postlabeling assay of DNA adducts.
    Lee CK, Brown BG, Bombick BR, Doolittle DJ.
    Anal Biochem; 1995 May 01; 227(1):156-61. PubMed ID: 7668376
    [Abstract] [Full Text] [Related]

  • 23. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
    Mourato LL, Beland FA, Marques MM.
    Chem Res Toxicol; 1999 Jul 01; 12(7):661-9. PubMed ID: 10409407
    [Abstract] [Full Text] [Related]

  • 24. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV, Randerath K.
    Environ Health Perspect; 1987 Dec 01; 76():41-7. PubMed ID: 2834194
    [Abstract] [Full Text] [Related]

  • 25. Development of methods for measuring biological markers of formaldehyde exposure.
    Fennell TR.
    Res Rep Health Eff Inst; 1994 Jun 01; (67):1-20; discussion 21-6. PubMed ID: 7917119
    [Abstract] [Full Text] [Related]

  • 26. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN, Weber WW.
    Anal Biochem; 1988 Nov 01; 174(2):381-92. PubMed ID: 3239743
    [Abstract] [Full Text] [Related]

  • 27. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S, Kim SY, Suzuki N.
    Methods Mol Biol; 2006 Nov 01; 314():307-21. PubMed ID: 16673890
    [Abstract] [Full Text] [Related]

  • 28. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K, Randerath E, Danna TF, van Golen L, Putman KL.
    Carcinogenesis; 1989 Jul 01; 10(7):1231-9. PubMed ID: 2544310
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
    Reddy MV, Bleicher WT, Blackburn GR, Mackerer CR.
    Carcinogenesis; 1990 Aug 01; 11(8):1349-57. PubMed ID: 2387021
    [Abstract] [Full Text] [Related]

  • 31. O6-alkyldeoxyguanosine detection by 32P-postlabeling and nucleotide chromatographic analysis.
    Wilson VL, Basu AK, Essigmann JM, Smith RA, Harris CC.
    Cancer Res; 1988 Apr 15; 48(8):2156-61. PubMed ID: 3349485
    [Abstract] [Full Text] [Related]

  • 32. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K, Randerath E, Agrawal HP, Gupta RC, Schurdak ME, Reddy MV.
    Environ Health Perspect; 1985 Oct 15; 62():57-65. PubMed ID: 3910421
    [Abstract] [Full Text] [Related]

  • 33. Standardization of the 32P-postlabeling assay for polycyclic aromatic hydrocarbon-DNA adducts.
    Shields PG, Harris CC, Petruzzelli S, Bowman ED, Weston A.
    Mutagenesis; 1993 Mar 15; 8(2):121-6. PubMed ID: 8464380
    [Abstract] [Full Text] [Related]

  • 34. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E, Schuler D, Budiawan.
    IARC Sci Publ; 1999 Mar 15; (150):219-32. PubMed ID: 10626223
    [Abstract] [Full Text] [Related]

  • 35. Detection of 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine occurring endogenously in DNA.
    Watson WP, Aston JP, Barlow T, Crane AE, Potter D, Brown T.
    IARC Sci Publ; 1999 Mar 15; (150):63-73. PubMed ID: 10626209
    [Abstract] [Full Text] [Related]

  • 36. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A, Maas LM, Van Breda SG, Curfs DM, Kleinjans JC, Wouters EF, Van Schooten FJ.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr 15; 9(4):367-72. PubMed ID: 10794480
    [Abstract] [Full Text] [Related]

  • 37. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG, Kato S, Bowman ED, Petruzzelli S, Cooper DP, Povey AC, Weston A.
    IARC Sci Publ; 1993 Apr 15; (124):243-54. PubMed ID: 8225491
    [Abstract] [Full Text] [Related]

  • 38. 32P-postlabelling analysis of bulky aromatic adducts.
    Gupta RC.
    IARC Sci Publ; 1993 Apr 15; (124):11-23. PubMed ID: 8225473
    [Abstract] [Full Text] [Related]

  • 39. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV, Smith CV, Randerath E, Randerath K.
    Carcinogenesis; 1994 Sep 15; 15(9):2061-4. PubMed ID: 7923604
    [Abstract] [Full Text] [Related]

  • 40. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL, Osborne MR, Hewer A, Phillips DH, Poirier MC.
    Cancer Res; 1999 Oct 01; 59(19):4829-33. PubMed ID: 10519392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.